Safety Study of CC312 in Autoimmune Disease Patients

Clinical trial NCT06888960 · RECRUITING

Trial details

NCT number: NCT06888960
Sponsor: CytoCares Inc
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathy (IIM)Systemic Sclerosis (SSc)Rheumatoid Arthritis (RA)Primary Immune Thrombocytopenia (ITP)Autoimmune Hemolytic Anemia

Start date: 2024-11-08
Primary completion: 2026-11-08
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.